ALGN vs. NBIX: A Head-to-Head Stock Comparison
UpdatedHere’s a clear look at ALGN and NBIX, comparing key factors like performance, valuation metrics, dividends, and financial strength. It’s built for investors or anyone curious to see how these two stocks match up.
Company Overview
With ALGN at 12.46 billion USD and NBIX at 11.82 billion USD, their market capitalizations sit in the same ballpark.
ALGN’s beta of 1.68 points to much larger expected swings compared to NBIX’s calmer 0.26, suggesting both higher upside and downside potential.
| Symbol | ALGN | NBIX |
|---|---|---|
| Company Name | Align Technology, Inc. | Neurocrine Biosciences, Inc. |
| Country | US | US |
| Sector | Healthcare | Healthcare |
| Industry | Medical - Devices | Drug Manufacturers - Specialty & Generic |
| CEO | Mr. Joseph M. Hogan | Mr. Kyle W. Gano Ph.D. |
| Price | 171.91 USD | 119.41 USD |
| Market Cap | 12.46 billion USD | 11.82 billion USD |
| Beta | 1.68 | 0.26 |
| Exchange | NASDAQ | NASDAQ |
| IPO Date | January 30, 2001 | May 23, 1996 |
| ADR | No | No |
Performance Comparison
This chart compares the performance of ALGN and NBIX over the past year by tracking the growth of an initial $10,000 investment in each (starting one year ago).
Hover over the lines to see the investment’s value and total return (%) at specific dates.
Data is adjusted for dividends and splits.
Valuation Metrics Comparison
For a detailed comparison of valuation metrics between ALGN and NBIX, please refer to the table below.
| Symbol | ALGN | NBIX |
|---|---|---|
| Price-to-Earnings Ratio (P/E, TTM) | 30.88 | 38.93 |
| Forward PEG Ratio (TTM) | 2.92 | 1.34 |
| Price-to-Sales Ratio (P/S, TTM) | 3.13 | 4.90 |
| Price-to-Book Ratio (P/B, TTM) | 3.33 | 4.70 |
| Price-to-Free Cash Flow Ratio (P/FCF, TTM) | 19.76 | 24.01 |
| EV-to-EBITDA (TTM) | 14.56 | 22.36 |
| EV-to-Sales (TTM) | 2.94 | 5.00 |
| EV-to-Free Cash Flow (TTM) | 18.56 | 24.52 |
Dividend Comparison
Neither ALGN nor NBIX currently pays a dividend yield; this often indicates they are reinvesting earnings for growth, prioritizing long-term expansion over immediate cash returns to shareholders.
| Symbol | ALGN | NBIX |
|---|---|---|
| Dividend Yield (TTM) | 0.00% | 0.00% |
Financial Strength Metrics Comparison
This section dives into the financial resilience of ALGN and NBIX, spotlighting key metrics like liquidity, leverage, and debt coverage. Check out the standout observations below where notable differences or extremes pop up.
- Neither ALGN nor NBIX records interest coverage (both “--”), indicating virtually no interest expense—usually a sign of negligible debt.
| Symbol | ALGN | NBIX |
|---|---|---|
| Current Ratio (TTM) | 1.21 | 3.13 |
| Quick Ratio (TTM) | 1.08 | 3.02 |
| Debt-to-Equity Ratio (TTM) | 0.03 | 0.18 |
| Debt-to-Assets Ratio (TTM) | 0.02 | 0.12 |
| Interest Coverage Ratio (TTM) | -- | -- |